Zhong Ji Longevity Science Group Limited reported that its share capital structure remained unchanged for the month ended 31 July 2026.

The company’s authorised share capital stood at 40.00 billion ordinary shares with a par value of HKD 0.01 each, equating to HKD 400.00 million. No increase or decrease in authorised capital was recorded during the month.

Issued share capital was stable at 636.65 million ordinary shares, with no treasury shares outstanding. Consequently, total issued shares (excluding treasury shares) stayed unchanged at 636.65 million.

Zhong Ji Longevity Science confirmed that it continued to meet the Main Board’s minimum public-float requirement of 25% as of 31 July 2026.

Under the share option scheme adopted on 12 June 2012, 3.87 million options granted on 31 December 2020 remained outstanding. No options were exercised, cancelled, or lapsed, leaving the potential issuance capacity under the scheme at 38.70 million shares. No new warrants, convertibles, or other equity-linked instruments were issued, and there were no repurchases or redemptions of shares.

The company’s capital base and ownership structure, therefore, exhibited stability through July, with no dilution to existing shareholders and full compliance with Hong Kong Stock Exchange listing requirements.